BiotechTube
Home/Biolojic Design/Roger Waltzman
RW

Roger Waltzman

Chief Medical Officer

Biolojic Design

Therapeutic Areas

Autoimmune DiseasesImmuno-oncology

Biolojic Design Pipeline

DrugIndicationPhase
TEV '325 (formerly BD9)Atopic Dermatitis, AsthmaPreclinical
Anti-TNFR2 Agonistic AntibodyTherapeutic (Treg modulation)Research/Preclinical

Leadership Team at Biolojic Design

NC
Neal Curran
Chief Business Officer
View full Biolojic Design profile